These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1295347)

  • 21. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 23. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine.
    Oda M; Izumiya K; Sato Y; Hirayama M
    J Infect Dis; 1983 Jul; 148(1):138-45. PubMed ID: 6309992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of Bordetella pertussis.
    He Q
    Pediatr Infect Dis J; 2016 Aug; 35(8):915-7. PubMed ID: 27213264
    [No Abstract]   [Full Text] [Related]  

  • 26. Surveillance of pertussis: methods and implementation.
    Guiso N; Wirsing von König CH
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):657-67. PubMed ID: 27224518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 29. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bordetella pertussis: current aspects and future prospects in public health].
    Martínez Pérez E
    An R Acad Nac Med (Madr); 1993; 110(1):105-24; discussion 125. PubMed ID: 8238816
    [No Abstract]   [Full Text] [Related]  

  • 33. Acellular pertussis vaccines for infants.
    Edwards KM; Decker MD
    N Engl J Med; 1996 Feb; 334(6):391-2. PubMed ID: 8538712
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?
    Cherry JD
    Expert Rev Vaccines; 2014 Sep; 13(9):1073-80. PubMed ID: 24985069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.
    Li Volti S; Mattina T; Mauro L; Bianca S; Anfuso S; Ursino A; Mollica F
    Childs Nerv Syst; 1996 Feb; 12(2):100-2. PubMed ID: 8674075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the true burden and infection dynamics of Bordetella pertussis using molecular diagnostics.
    Curran T; Coyle PV
    J Infect; 2016 Apr; 72(4):504-5. PubMed ID: 26826519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.